A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2 - Concepedia

Concepedia

Publication | Open Access

A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2

DOI Full Paper Access

30

Citations

35

References

2016

Year

Julia M. Greene, Erika J Schneble, Doreen O. Jackson, Diane F. Hale, Timothy J. Vreeland, Madeline Flores, Jonathan Martin, Garth S. Herbert, Mark O. Hardin, Xianzhong Yu,

Cancer Immunology Immunotherapy

Tumor ImmunologyCancer ImmunosurveillanceMelanomaImmunologyTherapeutic VaccineDendritic Cell BiologyStage Iv MelanomaImmunotherapyMedicineRadiation OncologyLow Dose Interleukin-2

References

	Year	Citations

Page 1

Page 1